brand logo

Am Fam Physician. 2005;71(12):2365-2366

Clinical Question: Are citalopram and fluoxetine effective therapies for vasomotor symptoms in menopausal women?

Setting: Outpatient (any)

Study Design: Randomized controlled trial (double-blinded)

Allocation: Concealed

Synopsis: In this well-designed clinical trial, 150 symptomatic, naturally menopausal women were assigned to one of three treatment groups: citalopram (10 mg), fluoxetine (10 mg), or placebo. The women were instructed to take one dose daily for month 1, two doses daily for months 2 through 6, and three doses daily after month 6, with permission to return to two doses per day if they experienced bothersome side effects. Only 30 women (approximately 60 percent) from each group completed the nine-month study, which was sufficient to detect a 20 percent difference in the principle outcome, the Kupperman index score, a frequently used menopause symptom index. No differences were noted in the Kupperman index scores during the study. No dose-response effect was observed as dosages increased.

No differences were found in other secondary measures, including number of hot flashes and Beck Depression Inventory score. Insomnia improved more in the citalopram group than in the placebo group. As in other studies of menopausal vasomotor symptoms, improvement over time was noted in all groups; approximately 60 percent of women in all three groups reported that vasomotor symptoms had decreased by one half or more at six months.

Bottom Line: Neither citalopram nor fluoxetine improved the vasomotor symptoms (i.e., hot flashes) of menopausal women more than placebo. As in other well-designed clinical trials of treatments for hot flashes, there was a marked placebo effect and improvement in all groups over time. (Level of Evidence: 1b)

POEMs (patient-oriented evidence that matters) are provided by Essential Evidence Plus, a point-of-care clinical decision support system published by Wiley-Blackwell. For more information, see http://www.essentialevidenceplus.com. Copyright Wiley-Blackwell. Used with permission.

For definitions of levels of evidence used in POEMs, see http://www.essentialevidenceplus.com/product/ebm_loe.cfm?show=oxford.

To subscribe to a free podcast of these and other POEMs that appear in AFP, search in iTunes for “POEM of the Week” or go to http://goo.gl/3niWXb.

This series is coordinated by Sumi Sexton, MD, editor-in-chief.

A collection of POEMs published in AFP is available at https://www.aafp.org/afp/poems.

Continue Reading


More in AFP

Copyright © 2005 by the American Academy of Family Physicians.

This content is owned by the AAFP. A person viewing it online may make one printout of the material and may use that printout only for his or her personal, non-commercial reference. This material may not otherwise be downloaded, copied, printed, stored, transmitted or reproduced in any medium, whether now known or later invented, except as authorized in writing by the AAFP.  See https://www.aafp.org/about/this-site/permissions.html for copyright questions and/or permission requests.